ArticleBlood neoplasia2026

Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDS.

H Josh Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.